Brief: China Resources Pharmaceutical Updates On FY Profit Estimates For Dong-E-E-Jiao
30/01/2023 23:26
Jan 31 (Reuters) - China Resources Pharmaceutical Group
Ltd 3320.HK :
* NET PROFIT ATTRIBUTABLE OF DONG-E-E-JIAO FOR YEAR
ESTIMATED TO
RANGE FROM RMB760 MILLION TO RMB810 MILLION
* SEES NET PROFIT EXCLUDING NON-RECURRING GAIN OR LOSS FROM
RMB686.37 MILLION TO RMB736.37 MILLION FOR DONG-E-E-JIAO FOR
YEAR
Source text for Eikon: ID:nHKSNRwDB
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals
Brief: China Resources Pharmaceutical Says CR Boya Bio-Pharmaceutical Posts Quarterly Unaudited Revenue RMB 321.1 Million, Net Profit RMB 30.0 Million